Announcement Search Results for

Winners of 2023 President’s Awards Announced

|

For Immediate ReleaseJune 30, 2023  MEMPHIS—University of Tennessee System President Randy Boyd announced the recipients of the 2023 President’s Awards. The announcement was made during the annual UT Board of Trustees meeting held in Memphis. Fourteen faculty and staff members from across the UT System received awards to celebrate their accomplishments and dedication to the Be… Read More


UTHSC Nominees for 2023 President’s Awards

|

The UT Health Science Center (UTHSC) has officially submitted its nominees to the UT System for the 2023 President’s Awards. Based on the BE ONE UT values, these awards are the highest honor a UT employee can receive. UTHSC’s 2023 nominees are: Dr. James Bailey – Bold and impactful (faculty) This award honors an individual who… Read More


UTHSC Has Another Record-Breaking Year for Research Grants, Contract Awards

|

The University of Tennessee Health Science Center (UTHSC) Office of Research has reported another record-breaking high for grant and contract awards received in a single fiscal year. The final numbers for UTHSC’s fiscal year ending June 30, 2022 (FY22) show annual grant and contract awards totaled $133 million, a $6.3 million increase from last year’s… Read More


UTHSC-led team lands cancer immunotherapy grant

|

Cancer immunotherapy is a form of cancer treatment that uses the body’s immune system to prevent, control, and eliminate cancer, and it’s become a popular method. But it often fails to cure patients, as the cancer cells can sidestep and inhibit the body’s anti-tumor response. Now, however, a team at the University of Tennessee Health… Read More


UTHSC-led team receives $3.16 million from National Cancer Institute for cancer immunotherapy drug development

|

A UTHSC-led team has received $3.16 million from the National Cancer Institute to develop a drug that boosts the immune system response in cancer patients to destroy tumor cells. Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in the Department of Physiology, is the lead investigator. Sue Chin Lee, PhD, associate professor in the… Read More


UTHSC-Led Team Receives $3.16 Million from National Cancer Institute for Cancer Immunotherapy Drug Development

|

A UTHSC-led team has received $3.16 million from the National Cancer Institute to develop a drug that boosts the immune system response in cancer patients to destroy tumor cells. Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in the Department of Physiology, is the lead investigator. Sue Chin Lee, PhD, associate professor in the… Read More


Ground-Breaking Research, Noteworthy Awards Presented at International Research Conference Hosted by UTHSC

|

Groundbreaking research on regenerative medicine and stem cell biology was recently presented at a major international conference recruited to Memphis by the University of Tennessee Health Science Center (UTHSC). Twenty national leaders in the field of regenerative medicine gave presentations at the International Experimental Biology and Medicine Conference (IEBMC), which took place earlier this month… Read More


‘We were so damn lucky to find this’: Tennesseans close to developing radiation exposure drug

|

Scientists in Tennessee are developing a promising drug they desperately hope will never be used. It’s a treatment that could rescue people from gastrointestinal acute radiation syndrome. In blunt terms, radiation poisoning. “We were so damn lucky to find this mechanism that nature invented for us,” said Dr. Gabor Tigyi, a cell biologist and cancer researcher… Read More